Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
Submitted by
admin
on December 9, 2011 - 9:39am
Source:
Bloomberg
News Tags:
JNJ
Pharmacyclics
PCI-32765
non-Hodgkin's lymphoma
Headline:
J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
Do Not Allow Advertisers to Use My Personal information
